European reach VISUfarma is a pan-European ophthalmic player with a growing portfolio and exclusive distributors in 20+ countries, presenting opportunities to expand sales through new markets and channel partnerships.

Strategic partnerships Recent licensing and collaboration deals with Tenpoint Therapeutics and Visus Therapeutics indicate openness to co‑development and licensing, suggesting sales opportunities through co-promotion, licensing, and distribution agreements.

Product pipeline Recent launches such as TREHAPAN and Xailin Ectoine demonstrate active product innovation in dry eye and ocular surface care, providing cross-selling and upsell potential across ophthalmology specialties.

Acquisition activity Historical ownership changes and potential acquisition discussions imply a dynamic growth trajectory; sales teams should engage on entering or expanding distribution and licensing conversations with an eye toward strategic partnerships.

Targeted segments Portfolio coverage spans dry eye, MGD, blepharitis, retinal health, supplements and glaucoma, enabling tailored pitches to ophthalmology clinics, distributors, and healthcare providers seeking comprehensive ocular health solutions.